Microsure announced today that it has closed an investment round with Innovation Industries, a leading hightech VC fund. Microsure is focused on the development and marketing of surgical robots that enable microsurgeons to perform surgeries with increased precision. With the investment, Microsure will accelerate the market introduction and sales of its systems.
Microsurgery is characterized by performing surgery close to the limits of what is physically possible. The Microsure motion stabilizer system is designed by and for microsurgeons who want to overcome their physical limitations and enhance their performance. By improving the quality of microsurgical procedures and by making them easier to perform, Microsure hopes to increase the number of treatment options for patients.
Raimondo Cau, Founder and Chief Technology Officer of Microsure states: “The extraordinary control and precision offered by the Microsure motion stabilizer provides better and more constant surgical outcome and allows the development of new highly accurate surgical procedures that are currently unavailable”.
Tom van Mulken, plastic surgeon at Maastricht UMC+ and Chief Medical Officer of Microsure and co-founder adds: “The past months the Microsure system is already successfully used in a first clinical trial with 8 micro-surgical operations for lymphedema in the Maastricht UMC+”.
“We are very excited about our investment in Microsure”, says Tom Schwarz, General Partner at Innovation Industries. “Microsure has the ability to change the way that microsurgery is performed. By using the Microsure system, surgeries will become more efficient and more effective.”
Founding institutes Eindhoven University of Technology and Maastricht UMC+ are delighted with the opportunity the financing round offers Microsure to further commercialize the system. “The investment by Innovation Industries shows the value and potential of the research that is done at the TU/e in the field of medical robotics” says Sonja Vos, Director TU/e Holding.
Microsure B.V. is a medical robotics company focused on micro surgery. The company develops, builds and commercializes innovative robotic solutions that offers surgeons super human precision. Microsure is a spin-off of Eindhoven University of Technology (TU/e) and is initiated by a collaboration of TU/e with Maastricht UMC+ combining the medical knowledge from Maastricht UMC+ with the high-tech precision mechatronics capabilities of the region Brainport Eindhoven.
Microsure was covered by the Dutch TV show “De Wereld Draait Door” on 25 February 2016.
Joost Horsten, interim CEO
Sjaak Deckers, Chairman Supervisory Board
+316 2249 0104
About Innovation Industries
Innovation Industries is an independent venture capital fund which aims to support Dutch tech ventures by providing both funding as well as hands-on guidance. In order to help Dutch tech ventures succeed, Innovation Industries has partnered with four technical universities (Eindhoven, Twente, Delft and Wageningen) as well as applied research institutes (TNO, ECN and DLO). The Innovation Industries Fund is supported by private and institutional investors such as PME and InnovFin Equity.
Tom Schwarz, General Partner
About Eindhoven University of Technology and TU/e Innovation Lab
Eindhoven University of Technology (TU/e) is a research-driven, design-oriented university of technology with a strong international focus. The university was founded in 1956, and has around 11,000 students and 3,000 staff. TU/e has defined strategic areas focusing on the societal challenges in Energy, Health and Smart Mobility.
Eindhoven University of Technology wants to contribute to society by translating the scientific and technological findings into products and services that help solve important societal issues. But how do you bridge the gap between knowledge and the market? TU/e Innovation Lab is the expert center that helps translating knowledge into business. For this purpose, there is an enthusiastic and experienced team of coaches, advisors and supervisors available to help TU/e staff and students as well as external parties.
About Maastricht UMC+
Maastricht University Medical Center+ is known both nationally and internationally for its focus on prevention. In other words, it goes beyond recovery alone to help people maintain and actively improve their health. In addition to top-level clinical diagnostics and top referral patient care, its core tasks are medical research and training, areas in which it is well known for its multidisciplinary and problem-based approach. Maastricht UMC+ has 715 beds, approximately 7000 staff and 4000 students. It is a member of the Netherlands Federation of University Medical Centres (see also www.nfu.nl). For more information, visit www.mumc.nl, www.mumc.tv, www.maastrichthealthcampus.nl, and www.maastrichtuniversity.nl.
 InnovFin Equity with the financial backing of the European Union under Horizon 2020 Financial Instruments and the European Fund for Strategic Investments (EFSI) set up under the Investment Plan for Europe. The purpose of EFSI is to help support financing and implementing productive investments in the European Union and to ensure increased access to financing.